Sharing Clinical Expertise on Combination Procedures

Daewoong Pharmaceutical and DNC Esthetics announced on August 3 that they held a specialized medical aesthetics training program, the 'Deep Symposium,' for healthcare professionals at the Ambassador Seoul Pullman Hotel on August 1.


Daewoong Pharmaceutical and DNC Esthetics 'Deep Symposium' Event. Daewoong Pharmaceutical

Daewoong Pharmaceutical and DNC Esthetics 'Deep Symposium' Event. Daewoong Pharmaceutical

View original image

In the recent medical aesthetics market, there is a growing clinical trend away from single product or single procedure approaches. Instead, practitioners are comprehensively considering patients' skin conditions, treatment objectives, and target areas to combine multiple products and treatments—referred to as 'combination procedures.' The symposium was organized to share clinical strategies and procedural know-how with healthcare professionals in line with this trend.


DEEP stands for 'Daewoong·DNC Aesthetics Medical-AEsthetic Expert Program,' and it is the joint educational program run by the two companies. This event was held under the theme "The Art of Synergy: From Skin Quality to Body Contouring," and was attended by more than 100 healthcare professionals and speakers.


The symposium covered combination treatment protocols and clinical application cases that maximize product synergy across various clinical scenarios, ranging from improving skin quality to upper body contouring. For instance, in the case of the botulinum toxin product 'Nabota,' methods were presented for combining 'NaboLift,' which targets muscle layer lifting and contouring, and 'NaboGlow,' which focuses on enhancing skin texture and tone in the dermal layer, depending on the patient's condition. In the upper body session, a combination protocol using the DCA fat destruction injection 'Violet' and the energy-based device 'ONDA' was shared. According to the companies, Violet is a product with clinical evidence for reducing arm fat in Korea.



Yoon Junsoo, Head of Nabota Business Division at Daewoong Pharmaceutical, said, "This symposium was an opportunity to expand the scope of procedures from the facial area to upper body contouring and to share new possibilities for combination treatments." Yoo Hyunseung, CEO of DNC Esthetics, stated, "We will continue to provide education and clinical insights to help create a safe and effective treatment environment."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing